QPPV.COM KNOWLEDGE ASSESSMENT

Knowledge Assessment: Controlled Access and Controlled Distribution of Medicines in the EU

Test your understanding of the concepts covered by Controlled Access and Controlled Distribution of Medicines in the EU: Non-Pregnancy Risk-Minimisation Approaches and Member State Implementation.

Question 1 of 10Pass mark: 80%

Question 1 of 10 Which data-management approach is most consistent with the article's governance principles?

Collect every potentially available data element to maximise future flexibility. Collect only data linked to a defined safety, oversight, effectiveness or quality objective and govern access and retention appropriately. Avoid collecting operational data because they are never pharmacovigilance-relevant. Allow all programme participants unrestricted access to patient and prescriber data.

Question 2 of 10 How should an MAH interpret differences in CAP/CDS workflows between Member States?

Any difference means that the EU-level risk-minimisation measure has failed. National differences may be appropriate if they preserve the common safety objective and critical control elements. All Member States must use identical registers, pharmacies and electronic systems. National implementation is outside the MAH's governance responsibilities.

Question 3 of 10 When does a required laboratory test function as an access control rather than merely as clinical monitoring?

When the test is listed in the product information, regardless of how results are used. When the result is required before supply or continuation and an unacceptable result prevents or changes the treatment decision. When the test is performed by a hospital laboratory rather than a community laboratory. When the test is repeated at least monthly.

Question 4 of 10 Which scenario most directly supports restricting prescribing to registered healthcare professionals?

The medicine has a high marketing budget. The medicine requires specialist diagnosis and clinical judgement to initiate safely. The medicine is available in more than one pack size. The medicine is supplied in a recyclable package.

Question 5 of 10 A proposed programme requires several registrations, manual forms and database checks, but the design team cannot identify which unsafe decision the programme is intended to control. What is the most appropriate professional concern?

The programme may be too focused on administrative complexity rather than a defined safety-critical decision. The programme is automatically invalid because all CAPs must use a single digital platform. The programme should be converted into a pregnancy prevention programme. The programme is adequate because the number of controls is proportional to the product's therapeutic potency.

Question 6 of 10 Which conclusion about non-pregnancy CAP/CDS measures is most accurate?

They are limited to preventing fetal exposure. They may address eligibility, diagnostic confirmation, specialist use, administration setting, monitoring, medication errors, misuse, diversion or supply-chain risks. They are applicable only to medicines with a narrow therapeutic margin. They are alternatives to product information and routine prescribing controls.

Question 7 of 10 What is the most appropriate interpretation of a 98% prescriber-registration rate?

It proves that inappropriate prescribing has been prevented. It is implementation evidence, but does not by itself demonstrate behavioural or clinical effectiveness. It proves that all patients met the treatment eligibility criteria. It demonstrates that the distribution chain was fully controlled.

Question 8 of 10 What is the most appropriate CAPA response when unauthorised dispensing occurs because the pharmacy system cannot verify prescriber status?

Retrain only the individual pharmacist involved and close the issue. Delete the dispensing record so that it cannot recur in reports. Address the systemic verification failure, potentially through a system, interface or responsibility change, and assess related impact. Suspend all pharmacovigilance activities for the product.

Question 9 of 10 A pharmacy is listed as an authorised dispenser, but it dispenses the product without checking whether the required prerequisite has been met. What does this indicate?

The pharmacy is functioning as an effective safety gate because it is authorised. The programme has a nominal control point, but the gate is not operating as intended. The issue is irrelevant because pharmacy authorisation is only a commercial decision. The issue proves that controlled distribution and controlled access are identical concepts.

Question 10 of 10 Why should a digital CAP/CDS be validated and monitored after implementation?

Software automatically ensures that a control cannot be bypassed. Digital systems can introduce failures such as duplicate records, unavailable results, incorrect matching or workarounds. Digital systems are permitted to replace all clinical judgement. Validation is needed only for systems used in manufacturing.

Knowledge Assessment: Controlled Access and Controlled Distribution of Medicines in the EU

Cookie Settings